Author | Lightnews

Reposted by Gwendolyn Wu

Gabrielle Hecht has no more spoons @gabriellehecht.bsky.social · 16d

Purdue to the rescue of IU student newspaper, whose institution was attempting censorship. Details in alt!

Sara Whitmer
• • •
1h • 8
I'm sure many of you have heard by now that earlier this week, IU k*lled the print edition of its student paper, the IDS. The issue that was supposed to print this week contained criticism of the Whitten regime and IUs further slide into scist control, and they couldn't allow that to happen during Homecoming, when all the rich alumni are in town.
Enter Purdue! The Purdue student paper, The Exponent, owns its own presses. Yesterday, in an act of tremendous solidarity with their biggest rival school, they printed the forbidden issue of the IDS. They then drove it to Bloomington overnight and stocked all of the IDS boxes on campus, just in time for Homecoming.
Solidarity is what makes us stronger, and solidarity will be what ultimately allows us to triumph, if we can ever truly get it together. I hope everyone has a fun, safe day if they're going out today, and I hope we can think about what acts of solidarity we can begin taking to really make this movement MOVE - beyond a permitted expression of upset into more active resistance.
75
12 comments

Gwendolyn Wu @gwendolynawu.bsky.social · Oct 2

A new target for colorectal cancer is the focus of #biosky biotech Cartography's lead program. “There’s still an opportunity to build the right molecule,” CEO Kevin Parker told @biopharmadive.com www.biopharmadive.com/news/cartogr...

Cartography secures $67M in pursuit of ‘differentiated’ cancer drugs

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be helpful treating the vast majority of colorectal cancer cases.

www.biopharmadive.com

2

Gwendolyn Wu @gwendolynawu.bsky.social · Sep 25

must-read from my colleague Jacob Bell on the how cancer pain meds haven't progressed much past opioids, and why that is: www.biopharmadive.com/news/cancer-... #biosky

Cancer patients are living longer than ever. Pain drugmakers haven’t kept up.

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily pain. Doctors fear that’s bound to continue.

www.biopharmadive.com

Gwendolyn Wu @gwendolynawu.bsky.social · Sep 11

Schizophrenia drug developer LB Pharmaceuticals priced the first major biotech IPO since February, selling more shares than originally forecast #biosky www.biopharmadive.com/news/lb-phar...

LB Pharmaceuticals raises $285M in first major biotech IPO since February

LB Pharmaceuticals, which has a schizophrenia medicine headed for late-stage testing, broke one of the longest droughts for large IPOs in years.

www.biopharmadive.com

2

Reposted by Gwendolyn Wu

elizabethcooney.bsky.social @elizabethcooney.bsky.social · Aug 28

This is telling: People I spoke to are talking about CDC in the past tense.

www.statnews.com/2025/08/28/c...

Crisis within CDC is spilling into real world, experts say

"I’ve never heard as many colleagues saying things like 'CDC is dead’ as I have today," an agency employee told STAT.

www.statnews.com

27 360 1K

Reposted by Gwendolyn Wu

STAT @statnews.com · Aug 26

The Department of Health and Human Services is terminating a National Institutes of Health grant program that supports students from marginalized backgrounds in the biomedical sciences. www.statnews.com/2025/08/25/n...

HHS terminates NIH program aimed at diversifying biomedical workforce

HHS is terminating a National Institutes of Health grant program that supports students from marginalized backgrounds in the biomedical sciences.

www.statnews.com

2 32 28

Reposted by Gwendolyn Wu

Pearl Freier @pearlf.bsky.social · Aug 26

From WSJ's story last night on Intel & the White House (gift link to story is also below) www.wsj.com/tech/inside-...

1

Gwendolyn Wu @gwendolynawu.bsky.social · Aug 21

Took a step out of biotech startup reporting today - Ionis Pharmaceuticals got approval from the FDA today for its hereditary angiodema drug Dawnzera. Its list price: $57,642 per dose. www.biopharmadive.com/news/ionis-d...

FDA approves Ionis’ hereditary angioedema drug

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

www.biopharmadive.com

2

Gwendolyn Wu @gwendolynawu.bsky.social · Aug 18

latest from the @biopharmadive.com team - researchers and investors weigh in on how cuts to mRNA research may make the U.S. fall behind other countries #biosky www.biopharmadive.com/news/mrna-va...

Kennedy’s mRNA cuts could set US science back, experts warn

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it harder to invest in companies advancing the technology.

www.biopharmadive.com

3 1

Reposted by Gwendolyn Wu

Marshall Project Guild @marshallprojectguild.org · Aug 14

Today, we sent a letter to @themarshallproject.org‬ leadership expressing concern about their denial of bargaining obligations. Management has repeatedly denied members Weingarten rights, engaged in an illegal layoff, and more — we need your help to demand that management bargain in good faith.

Dear Katrice and Geraldine,

We are deeply concerned about the manner in which The Marshall Project has been treating our members and approaching the bargaining process. Recently, The Marshall Project leadership has betrayed our organization’s values and compromised our position in the industry and the journalism we pursue. It’s time for that to change.

The guild has worked tirelessly and in good faith on proposals that would keep high-quality health care affordable for Marshallers. We have also been steadfast in asserting that all recognized members deserve due process and fair treatment required under the law.

The organization, in turn, has increasingly taken anti-worker stances that have eroded trust and created a culture that makes it difficult to do the work that makes us proud. Since the organization has taken such a hardline stance, refusing to work with the guild on the items listed below, we will be filing unfair labor practices with the National Labor Relations Board and stepping up our public efforts to make it clear that we demand fair treatment.

The following recent actions by the organization have taken an immense toll on the workers of The Marshall Project:

1. The organization has repeatedly denied steward representation to a member facing a Performance Improvement Plan and possible termination, as well as denying another member representation in their termination meeting last week. This denial is illegal, egregious, and completely out of line with standards across our industry and the labor movement going back decades. We are shocked that the organization would take such a hypocritical and prohibitive stance on this, given our mission. The union has filed an Unfair Labor Practice about this illegal violation of members’ Weingarten rights and demands that members be allowed steward representation in any meeting they feel is appropriate.

2. The organization has caused a retaliatory ripple effect with its actions against one employee that has touched an entire newsroom in Cleveland with negative effects that go against the stated purpose of collaboration with local media and our ability to make good on promises we made to readers. When the organization recognized members it had a duty to follow the law and not proceed with layoffs without bargaining. We have filed an Unfair Labor Practice for the illegal layoff of employees and management retaliation.

3. The organization made a unilateral change to our outside employment policy without bargaining, changing expectations to require managerial approval. We have always maintained a workplace where outside work is permitted and the organization’s sudden termination of Chris Vazquez without a steward, without an opportunity to stop the freelancing project, and without severance is unjust and defies our values.

4. The organization is employing a strategic erosion of status quo through small changes to past practice while we bargain our first contract, including erasure of our cost-of-living adjustment, a significant change to our health insurance, and modifying the evaluation process. The organization has inconsistently complied with requests for information, which does not reflect good faith in bargaining.

The Marshall Project, in retaining union-busting law firm Kauff McGuire & Margolis, is willingly participating in the erosion of worker protections across our industry, a project that takes advantage of the current anti-worker political environment. When The Marshall Project voluntarily recognized our union last year, it touted a “longstanding commitment to a fair, equitable and inclusive workplace, with generous benefits.” We are demanding a return to these values.

4 47 88

Gwendolyn Wu @gwendolynawu.bsky.social · Aug 4

In the latest move to get rid of "zombie" biotechs, Xoma Royalty will acquire HilleVax and Lava Therapeutics, two companies that have struggled since clinical testing of their lead drug candidates failed last year:. #biosky www.biopharmadive.com/news/xoma-hi...

Xoma strikes deals to buy struggling biotechs HilleVax, Lava

The royalty aggregator’s proposed deals for HilleVax and Lava add to a pattern of “zombie” biotech buyouts this year as the sector’s struggles continue.

www.biopharmadive.com

Reposted by Gwendolyn Wu

Jonathan Wosen @jonathanwosen.bsky.social · Aug 4

"A region known for its seemingly endless summer is still awaiting the end of the biotech winter that has swept up much of the industry." My latest for @statnews.com on the state of biotech in San Diego
www.statnews.com/2025/08/04/s...

Uncertainty clouds the San Diego biotech hub, with jobs and capital scarce

Many San Diego biotech firms are struggling to raise money, with the uncertainty exacerbated by the Trump administration’s disruptions to science.

www.statnews.com

1 4

Reposted by Gwendolyn Wu

Karen K. Ho @karenho.bsky.social · Jul 31

This is a really well-written profile, and worth the time to read. There's also a line that immediately made my eyes water: www.washingtonpost.com/parenting/in...

Ms. Rachel grew up on Mister Rogers. Now she’s carrying on his legacy.

The YouTube star wants her audiences — adults and children alike — to see the humanity of all people.

www.washingtonpost.com

1 20 110

Reposted by Gwendolyn Wu

Capital & Main @capitalandmain.bsky.social · Jul 8

In a video appearance with an immigration judge, a detainee pulled out a jar of bright red blood and set it on the table in front of him. Many of the people in the courtroom gasped in unison.

“I have cancer. This is the blood I’ve lost today.”

capitalandmain.com/with-a-jar-o...

With a Jar of Blood as Evidence, Detained Man Tells Immigration Judge ‘I am Dying Little by Little’

Judge denies bond for Guatemalan man worried about colon cancer as his condition appears to have grown worse in recent court hearings.

capitalandmain.com

1 39 88

Gwendolyn Wu @gwendolynawu.bsky.social · Jul 8

Targeted protein degradation has been a huge focus of #biosky and investors over the past decade. I dove into why for @biopharmadive.com:

www.biopharmadive.com/news/protein...

Protein degraders: chasing undruggable targets

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over the past two decades.

www.biopharmadive.com

1

Reposted by Gwendolyn Wu

Andrew Dunn @andrewedunn.bsky.social · Jun 24

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say
endpoints.news/sources-fda-...

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say

FDA Commissioner Marty Makary reportedly attempted to reject KalVista Pharmaceuticals' drug application, sources said. An HHS spokesperson calls the claim 'totally false.'

endpoints.news

5 7

Reposted by Gwendolyn Wu

Keri Blakinger @keribla.bsky.social · Jun 24

Houston police called ICE on a woman who called 911 to report domestic abuse by her ex-husband.

The only reason she didn't get deported is because ICE said there was no one to take custody of her kids, according to the police report. www.houstonchronicle.com/news/houston...

She called 911 to report domestic abuse. Then Houston police called ICE on her.

The woman’s case is a worst-case scenario, according to advocates worried about the worsening state of domestic violence in the Houston region.

www.houstonchronicle.com

65 690 1.3K

Reposted by Gwendolyn Wu

Laura Weiss @lauralew105.bsky.social · Jun 19

“Recent policy changes around COVID-19 vaccines are already sowing chaos and confusion and restricting vaccine access — including for people who should still be eligible to receive them.”
I wrote about RFK Jr’s anti-vax chaos for @thesicktimes.bsky.social. thesicktimes.org/2025/06/19/t...

The federal government is restricting COVID-19 vaccine access. Here’s what that means for the ongoing pandemic and people with Long COVID. - The Sick Times

Recent policy changes around COVID-19 vaccines are already sowing chaos and confusion and restricting vaccine access — including for people who should still be eligible to receive them.

thesicktimes.org

12 59 130

Reposted by Gwendolyn Wu

Lizzy Lawrence @lizzylawrence.bsky.social · Jun 20

EXCLUSIVE: The ouster of Nicole Verdun, the FDA's chief regulator of cell and gene therapies, came after disagreements over the review of Capricor's Duchenne therapy. At the same time, some have taken issue with Verdun's management style. Details below:
www.statnews.com/2025/06/20/f...

Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a drug review, STAT has learned.

www.statnews.com

2 8 5

Gwendolyn Wu @gwendolynawu.bsky.social · Jun 20

A dismal investment climate for publicly traded biotech companies is causing startups and their backers to tighten their belts, investors and analysts say. Latest for @biopharmadive.com #biosky

www.biopharmadive.com/news/biotech...

A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups

A dramatic pullback in public biotech investment catalyzed by economic and regulatory upheaval is putting even more stress on startups navigating a yearslong downturn.

www.biopharmadive.com

Reposted by Gwendolyn Wu

Fenit Nirappil @fenitn.bsky.social · May 27

Before RFK Jr. announced healthy children no longer need coronavirus vaccines, the CDC’s data showed more than half of young children admitted to the ICU for covid had no underlying conditions wapo.st/4kk4DlE

RFK Jr. ends coronavirus shot recommendation for healthy children, pregnant women

Currently the vaccine is recommended for all people over 6 months of age.

wapo.st

13 130 240

Reposted by Gwendolyn Wu

Liz Szabo @lizszabo.bsky.social · May 28

Good reporting from @nbcnews.com: As use of dietary supplements grow, so do rates of liver injuries. Most people who take dietary or herbal supplements do so on their own, not under a doctor’s advice.
www.nbcnews.com/health/healt...

Drug-induced liver injuries rise in the U.S. as supplements grow in popularity: What to know

Most people who take dietary or herbal supplements do so on their own, not under a doctor’s advice.

www.nbcnews.com

2 7 10

Reposted by Gwendolyn Wu

Gabriel San Román @gsanroman2.bsky.social · May 28

Eric Licas is such an intrepid reporter whose Orange County stories reached wide audiences with no engagement help from the LA Times parent company, which noticed him for a layoff amid their financial troubles.

Your news organization would be blessed to have him.

Eric Licas @ericlicas.bsky.social · May 28

I was just notified I'll be laid off from the Daily Pilot. Many thanks to the people of coastal Orange County for allowing me to get to know them and trusting me with their stories. I've always considered it an honor and privilege to do this work, and hope I'll be able to continue.

4 7

Reposted by Gwendolyn Wu

Emily L. Hauser (she/her) ❌👑 @emilylhauser.bsky.social · May 21

🧵I counseled sexual assault survivors for many years at a crisis center; I've been an advocate and activist in that space since high school.

And this is what every rapist thinks: "I have far more at stake and to lose than any other source in this piece." Always.

Olivia Messer @oliviamesser.bsky.social · May 21

Some of y’all noticed I’ve been uncharacteristically offline. This is why, and I remain on leave for a few weeks to handle a PTSD relapse. CJR was dogged in its pursuit of my story. Because of what I do and who I am, I felt that I had to answer their questions honestly.

www.cjr.org/feature-2/we...

Journalists Attest to Experiences of Sexual Misconduct with Wesley Lowery

Lowery rose to prominence as a reporter and media thinker. Women in the industry say he engaged in sexual harassment and assault.

www.cjr.org

3 35 150

Gwendolyn Wu @gwendolynawu.bsky.social · May 21

thank you for speaking up - I hope you keep healing and finding some peace amid all this 💗

7